首页> 外文期刊>Journal of industrial microbiology & biotechnology >Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria
【24h】

Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria

机译:含氰基氰基细菌的共同培养物激活静音生物合成途径和小型代谢产物的发现

获取原文
获取原文并翻译 | 示例
           

摘要

Bacterial secondary metabolites (SM) are rich sources of drug leads, and in particular, numerous metabolites have been isolated from actinomycetes. It was revealed by recent genome sequence projects that actinomycetes harbor much more secondary metabolite-biosynthetic gene clusters (SM-BGCs) than previously expected. Nevertheless, large parts of SM-BGCs in actinomycetes are dormant and cryptic under the standard culture conditions. Therefore, a widely applicable methodology for cryptic SM-BGC activation is required to obtain novel SM. Recently, it was discovered that co-culturing with mycolic-acid-containing bacteria (MACB) widely activated cryptic SM-BGCs in actinomycetes. This combined-culture methodology (co-culture methodology using MACB as the partner of actinomycetes) is easily applicable for a broad range of actinomycetes, and indeed, 33 novel SM have been successfully obtained from 12 actinomycetes so far. In this review, the development, application, and mechanistic analysis of the combined-culture method were summarized.
机译:细菌次级代谢物(SM)是具有丰富的药物引线来源,特别是从放线菌中分离出许多代谢物。最近的基因组序列项目揭示了放线菌源的序列,其涉及比以前预期的更次级代谢物 - 生物合成基因簇(SM-BGC)。然而,在标准培养条件下,放线菌中的SM-BGCs的大部分部分是休眠和神秘的。因此,需要一种广泛适用的隐秘SM-BGC激活方法来获得新颖的SM。最近,发现与含霉菌酸的细菌(MACB)共同培养在放线菌中的广泛活化的隐秘SM-BGC。这种组合培养方法(使用MacB作为放线菌的合作伙伴培养方法)很容易适用于广泛的放线菌,因此,到目前为止,33种新型SM已从12个放线菌成功获得。在本综述中,总结了合并培养方法的开发,应用和机械分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号